Your account is not claimed yet. You can sign up with ORCID to claim your account.

Anders Jakobsen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Cancers

Therapeutic advances in medical oncology

Acta oncologica (Stockholm, Sweden)

Future oncology (London, England)

Vejle Hospital - University Hospital of Southern Denmark

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vejle Hospital - University Hospital of Southern Denmark

Denmark

Professor :: Department of Oncology

Publications

Karen-Lise Garm Spindler, Anders Jakobsen
Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors - can we RECIST? Focus on colorectal cancer. Therapeutic advances in medical oncology 15 (2023)
Karen-Lise Garm Spindler, Anders Jakobsen
Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors - can we RECIST? Focus on colorectal cancer. Therapeutic advances in medical oncology 15 (2023)
Sara Witting Christensen Wen, Line Nederby, Rikke Fredslund Andersen, Torben Frøstrup Hansen, Christa Haugaard Nyhus, Ole Hilberg, Anders Jakobsen, Torben Frøstrup Hansen
NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. British journal of cancer (2023)
Louise Faaborg, Rikke Fredslund Andersen, Sara Wc Wen, Caroline B Thomsen, Louise Raunkilde, Torben Frøstrup Hansen, Lars Henrik Jensen, Karina Dahl Steffensen, Anders Jakobsen
Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer. Future oncology (London, England) (2023)
Sara Witting Christensen Wen, Jan Wen, Torben Frøstrup Hansen, Anders Jakobsen, Ole Hilberg
Cell Free Methylated Tumor DNA in Bronchial Lavage as an Additional Tool for Diagnosing Lung Cancer-A Systematic Review. Cancers 14 (9) (2022)
Edina Dizdarevic, Torben Frøstrup Hansen, Anders Jakobsen
The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal. Cancers 14 (9) (2022)
Louise Faaborg, Rikke Fredslund Andersen, Marianne Waldstrøm, Jon Røikjær Henriksen, Parvin Adimi, Anders Jakobsen, Karina Dahl Steffensen
Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer. Cancers 14 (7) (2022)
Louise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen, Niels Pallisgaard, Stine Kramer, Sven Schlander, Søren Rafael Rafaelsen, Anders Kindberg Boysen, Lars Henrik Jensen, Anders Jakobsen, Karen-Lise Garm Spindler
OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer - a ctDNA-guided phase II randomised approach. Study protocol. Acta oncologica (Stockholm, Sweden) 61 (9) (2022)
Karen Lycke Wind, Lisbeth Riber, Birgitte Mayland Havelund, Eva Serup-Hansen, Camilla Kronborg, Mette Marie Fode, Anders Jakobsen, Karen-Lise Garm Spindler
Intensified Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Anus-A Population-Based Experience from the Danish Anal Cancer Group. Cancers 13 (13) (2021)
Sara Witting Christensen Wen, Rikke Fredslund Andersen, Kristian Rasmussen, Caroline Emilie B Thomsen, Torben Frøstrup Hansen, Line Nederby, Henrik Hager, Anders Jakobsen, Ole Hilberg
Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer. Cancers 13 (16) (2021)
Karen Lycke Wind, Eva Serup-Hansen, Birgitte Mayland Havelund, Lisbeth Riber, Camilla Jensenius Skovhus Kronborg, Anders Jakobsen, Karen-Lise Garm Spindler
Definitive therapy for squamous cell carcinoma of the anus with synchronous metastases - a report from the Danish Anal Cancer Group. Acta oncologica (Stockholm, Sweden) (2021)
Sara Witting Christensen Wen, Rikke F Andersen, Lena Marie S Petersen, Henrik Hager, Ole Hilberg, Anders Jakobsen, Torben Frøstrup Hansen
Comparison of Mutated KRAS and Methylated HOXA9 Tumor-Specific DNA in Advanced Lung Adenocarcinoma. Cancers 12 (12) (2020)
Lars Henrik Jensen, René Olesen, Lone Noergaard Petersen, Anders Kindberg Boysen, Rikke Fredslund Andersen, Jan Lindebjerg, Lise Nottelmann, Caroline Emilie Brenner Thomsen, Birgitte Mayland Havelund, Anders Jakobsen, Torben Frøstrup Hansen
NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer. Cancers 11 (11) (2019)

Anders Jakobsen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anders Jakobsen